{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T17:33:11Z","timestamp":1648834391310},"reference-count":49,"publisher":"Informa Healthcare","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1185\/030079907x219472","type":"journal-article","created":{"date-parts":[[2007,7,21]],"date-time":"2007-07-21T19:01:03Z","timestamp":1185044463000},"page":"2027-2034","source":"Crossref","is-referenced-by-count":5,"title":["Impact of new Joint British Societies\u2019 (JBS 2) guidelines on prevention of cardiovascular disease: evaluation of serum total cholesterol goal achievement in UK clinical practice"],"prefix":"10.1185","volume":"23","author":[{"given":"Srinivasan","family":"Rajagopalan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evo","family":"Alemao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz","family":"Finch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2007,7,19]]},"reference":[{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.80.1.1"},{"issue":"5","key":"CIT0004","first-page":"v1","volume":"91","author":"Joint British Societies","year":"2005","journal-title":"Heart"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.2.207"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00298-1"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.11.1307"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050461"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.19.2437"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.21.2476-b"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.21.2476-c"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02610-4"},{"key":"CIT0013","first-page":"1084","volume":"90","author":"Gagn\u00e9 C","year":"2002","journal-title":"Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000068312.21969.C8"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.03.052"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1185\/030079904125004213"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.4065\/80.5.587"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.060"},{"key":"CIT0019","first-page":"619","volume":"59","author":"Cruz-Fernandez JM","year":"2005","journal-title":"Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease. Int J Clin Pract"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.11.023"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X382004"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.4.4.461"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"251","DOI":"10.18553\/jmcp.2004.10.3.251","volume":"10","author":"Armstrong EP","year":"2004","journal-title":"J Manag Care Pharm"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)02338-4"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/107424849600100204","volume":"1","author":"Stein EA","year":"1996","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2003.10.004"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2004.00450.x"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00708.x"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00646.x"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X59139"},{"key":"CIT0031","first-page":"208","volume":"164","author":"Simons LA","year":"1996","journal-title":"Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust"},{"key":"CIT0032","first-page":"670","volume":"11","author":"Thiebaud P","year":"2005","journal-title":"Am J Manag Care"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000180901.70607.72"},{"key":"CIT0035","first-page":"263","volume":"13","author":"Fornengo P","year":"2000","journal-title":"Diabetes Nutr Metab"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504273321703"},{"key":"CIT0037","first-page":"76","volume":"30","author":"Troein M","year":"2002","journal-title":"Changes in health beliefs after labelling with hypercholesterolaemia. Scand J Public Health"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.21.jed60074"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1111\/j.1520-037X.2005.3939.x"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.13.1597"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01428-6"},{"key":"CIT0042","first-page":"851","volume":"53","author":"Durack-Brown I","year":"2003","journal-title":"Patients\u2019 and physicians\u2019 perceptions and experience of hypercholesterolemia: a qualitative study. Br J Gen Pract"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050100"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.9.851"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.11.1238"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.15.1458"},{"key":"CIT0047","first-page":"684","volume":"53","author":"Kedward J","year":"2003","journal-title":"Br J Gen Pract"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/19.6.596"},{"key":"CIT0049","first-page":"2563","volume":"296","author":"Lee JK","year":"2006","journal-title":"Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-4-23"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"issue":"3","key":"CIT0053","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00019053-200422003-00003","volume":"22","author":"Benner JS","year":"2004","journal-title":"Pharmacoeconomics"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079907X219472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T07:14:14Z","timestamp":1629443654000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079907X219472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,19]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2007,6,22]]},"published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1185\/030079907X219472"],"URL":"https:\/\/doi.org\/10.1185\/030079907x219472","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,19]]}}}